Skip To Main Content
Gillian Bartlett-Esquilant on Muck Rack

Gillian Bartlett-Esquilant

As seen in: European Respiratory Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gillian

Contact Gillian, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs

|
By Lisa Ronald, J. Mark FitzGerald, Columbia, Gillian Bartlett-Esquilant
| European Respiratory Journal Verified
Lisa A. Ronald, J. Mark FitzGerald, Gillian Bartlett-Esquilant, Kevin Schwartzman, Andrea Benedetti, Jean-François Boivin, Dick Menzies European Respiratory Journal 2020 55: 1902048; DOI: 10.1183/13993003.02048-2019 Abstract Clinical trials suggest less hepatotoxicity and better adherence with 4 months rifampin (4R) versus 9 months isoniazid (9H) for treating latent tuberculosis infection (LTBI).
Open in Who Shared Issue with article?

Treatment with Isoniazid or Rifampin for Latent Tuberculosis Infection: Population-Based Study of Hepatotoxicity, Completion, and Costs

|
By Lisa Ronald, J. Mark FitzGerald, Kevin Schwartzman, Gillian Bartlett-Esquilant
| European Respiratory Journal Verified
Lisa A. Ronald, J. Mark FitzGerald, Gillian Bartlett-Esquilant, Kevin Schwartzman, Andrea Benedetti, Jean-François Boivin, Dick Menzies European Respiratory Journal 2020; DOI: 10.1183/13993003.02048-2019 Abstract Background Clinical trials suggest less hepatotoxicity and better adherence with 4 months rifampin (4R) versus 9 months isoniazid (9H) for treating latent tuberculosis infection (LTBI).
Open in Who Shared Issue with article?
See all 2 articles